Madden Securities’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,155
Closed -$1.03M 116
2025
Q1
$1.03M Sell
9,155
-4,345
-32% -$448K 0.4% 61
2024
Q4
$1.25M Sell
13,500
-8,340
-38% -$751K 0.5% 49
2024
Q3
$1.83M Sell
21,840
-400
-2% -$30.5K 0.79% 34
2024
Q2
$1.53M Buy
22,240
+2,175
+11% +$145K 0.68% 39
2024
Q1
$1.47M Buy
+20,065
New +$1.54M 0.68% 40
2023
Q4
Sell
-2,782
Closed -$208K 97
2023
Q3
$208K Buy
2,782
+4
+0.1% +$308 0.12% 82
2023
Q2
$214K Sell
2,778
-197
-7% -$15.7K 0.11% 83
2023
Q1
$247K Sell
2,975
-222
-7% -$18.4K 0.13% 82
2022
Q4
$274K Sell
3,197
-121
-4% -$9.58K 0.14% 83
2022
Q3
$205K Sell
3,318
-296
-8% -$18.7K 0.12% 93
2022
Q2
$223K Buy
3,614
+4
+0.1% +$248 0.12% 90
2022
Q1
$215K Sell
3,610
-3,446
-49% -$220K 0.1% 111
2021
Q4
$512K Sell
7,056
-922
-12% -$63.5K 0.24% 71
2021
Q3
$557K Buy
7,978
+929
+13% +$65.3K 0.3% 69
2021
Q2
$485K Sell
7,049
-47
-0.7% -$3.14K 0.25% 94
2021
Q1
$459K Sell
7,096
-1,196
-14% -$77.1K 0.27% 93
2020
Q4
$483K Buy
+8,292
New +$500K 0.31% 87

Other funds holding GILD

Madden Securities's GILD Position: Q2 2025 in Review

Madden Securities sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 9,155 shares — an estimated $1.03M sold.

Madden Securities first reported a position in GILD in Q4 2020 and held it in 17 quarters. The position peaked at $1.83M in Q3 2024. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Madden Securities reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Madden Securities sold 9,155 Gilead Sciences shares in Q2 2025, an estimated $1.03M.
  • Madden Securities first reported a position in Gilead Sciences in Q4 2020 and held it in 17 quarters.
  • Madden Securities's Gilead Sciences position peaked at $1.83M in Q3 2024.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Madden Securities's 13F filing for Q2 2025, filed 23 Jul 2025.